Company news

Lumos Diagnostics Holdings Ltd. news in 2025

Lumos Diagnostics Holdings Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Lumos Secures 100% US Medicare Reimbursement for FebriDx

November 21, 2025

Lumos secures follow-on PKU contract with Aptatek

August 31, 2025

LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study

August 31, 2025

FY25 Appendix 4E

August 27, 2025

Lumos Announces FebriDx CLIA Waiver Application Submission

August 17, 2025

Lumos Signs Binding Term Sheet for A$5M Loan Facility

July 17, 2025

Reinstatement to Quotation

July 16, 2025

Lumos Signs Pivotal US FebriDx Agreement

July 16, 2025

Suspension from Quotation

July 14, 2025

Pause in Trading

July 11, 2025

Lumos Reaches FebriDx CLIA Waiver Study Enrolment Milestone

June 18, 2025

Lumos Reaches Recruitment Milestone in FebriDx Study

June 1, 2025

Lumos Secures Sixth US Medicare Reimbursement for FebriDx

May 26, 2025

Lumos Secures Fifth US Medicare Reimbursement for FebriDx

May 19, 2025

Lumos Advances FebriDx Sales with iMedical Purchase Order

May 13, 2025

Lumos Secures Further US Medicare Reimbursement for FebriDx

April 23, 2025

Lumos Secures Key US Reimbursement Milestones for FebriDx

April 17, 2025

Hologic Development Agreement Expanded Scope of Works

March 2, 2025

Calls in 2025

Decks in 2025